Shocking HIV out of hiding: where are we with clinical trials of latency reversing agents?
Thomas A Rasmussen, Sharon R Lewin
Current Opinion in HIV and AIDS | LIPPINCOTT WILLIAMS & WILKINS | Published : 2016
This work was partly supported by funding from the National Health and Medical Research Council (NHMRC) of Australia.S.R.L.'s institution has received funding from the National Health and Medical Research Council (NHMRC) of Australia, National Institutes for Health, American Foundation for AIDS Research; Merck, Viiv, Gilead and Tetralogic for investigator initiated research; Merck, Viiv and Gilead for educational activities.